Youll also need to have no conditions that could interact with the active ingredient or make it unsafe to take
There are several Phase 3 trials evaluating GLP-1s for conditions, such as prediabetes, Alzheimer's disease, diabetic retinopathy and osteoarthritis of the knee (in patients with obesity)
Eicosapentaenoic acid lowered plasma sICAM-1 and sVCAM-1 in MetS patients
Checking coverage early is essential: Before starting either medication, review your insurance policy and look into financial assistance programs if needed
Individualized HRT regimenstailored to your needs and medical historycan prevent joint pain, mood swings, and unwanted metabolic shifts that sometimes accompany significant weight loss
With skyrocketing demand for semaglutide and tirzepatide (popularized under brand names Ozempic, Wegovy, Zepbound, and Mounjaro), the stage was set for a compounding boom